Skip to content

The effect of midazolam in decreasing time of hydrostatic reduction of childhood intussusceptions

The effect of midazolam in decreasing time of hydrostatic reduction of childhood intussusceptions

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT138904264395N1
Enrollment
32
Registered
2011-08-26
Start date
2011-07-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

invagination. Intussusception

Interventions

Intervention 1: intervention in case group with 0.1 mg per kilogram of midazolam as once IV injection (up to 3 miligram) from Exir company. Intervention 2: Intervention in control group with IV injec
Treatment - Other
Treatment - Drugs
intervention in case group with 0.1 mg per kilogram of midazolam as once IV injection (up to 3 miligram) from Exir company
Intervention in control group with IV injection of distilled water

Sponsors

Vice chancellor for research, Babol University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 4 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria are: The 6 mo-4 y old children with certain diagnosis of ileocolic intussusception referring to Amirkola Children's Hospital. Exclusion criteria are: The pathologic lead point existence ; the known case of chronic gastrointestinal disease as celiac or cystic fibrosis; the history of chronic pulmonary disease or hypoxia or cyanotic disease; the signs of peritonitis or bowel perforation; dehydration; letargia

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Time of reduction. Timepoint: 20 - 30 minutes after midazolam IV injection. Method of measurement: with questionnaire.

Secondary

MeasureTime frame
Success in reduction. Timepoint: one hour after midazolam injection. Method of measurement: observation.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRahele Mehraeen

Babol university of medical science

sany_monzavi@yahoo.com+98 911 126 3057

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026